HomeInsightsStock Comparison

Auro Laboratories Ltd vs Jagsonpal Pharmaceuticals Ltd Stock Comparison

Auro Laboratories Ltd vs Jagsonpal Pharmaceuticals Ltd Stock Comparison

Last Updated on: Dec 18, 2025

Key Highlights

  • The Latest Trading Price of Auro Laboratories Ltd is ₹ 247.25 as of 18 Dec 15:30.
  • The P/E Ratio of Auro Laboratories Ltd changed from 4.8 on March 2020 to 78.2 on March 2025 . This represents a CAGR of 59.22% over 6 yearsThe P/E Ratio of Jagsonpal Pharmaceuticals Ltd changed from 5.8 on March 2020 to 25.9 on March 2025 . This represents a CAGR of 28.33% over 6 years.
  • The Market Cap of Auro Laboratories Ltd changed from ₹ 19.6 crore on March 2020 to ₹ 143.69 crore on March 2025 . This represents a CAGR of 39.38% over 6 yearsThe Market Cap of Jagsonpal Pharmaceuticals Ltd changed from ₹ 45.72 crore on March 2020 to ₹ 1433 crore on March 2025 . This represents a CAGR of 77.58% over 6 years.
  • The revenue of Auro Laboratories Ltd for the Sep '25 is ₹ 9.81 crore as compare to the Jun '25 revenue of ₹ 3.19 crore. This represent the growth of 207.52% The revenue of Jagsonpal Pharmaceuticals Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Auro Laboratories Ltd for the Sep '25 is ₹ 3.33 crore as compare to the Jun '25 ebitda of ₹ 0.45 crore. This represent the growth of 640% The ebitda of Jagsonpal Pharmaceuticals Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Auro Laboratories Ltd changed from ₹ 0.75 crore to ₹ 0.72 crore over 4 quarters. This represents a CAGR of -4.00% The net profit of Jagsonpal Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Auro Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Jagsonpal Pharmaceuticals Ltd changed from 16.65 % on March 2020 to 29.99 % on March 2025 . This represents a CAGR of 10.30% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Auro Laboratories Ltd

  • Auro Laboratories Ltd, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API).
  • Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes.
  • The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra.
  • The facility has all the required certifications from Indian authorities and European registration organization Since inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards.
  • Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA. The Company's primary focus was on Anti-Diabetic Drugs, which estimated to be one of the fastest growing therapeutic segments.

About Jagsonpal Pharmaceuticals Ltd

  • Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana.
  • The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs.
  • Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India.
  • It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.
  • In 1994, the company has also promoted Aresco Financial Services, a new financial company.

Auro Laboratories Ltd News Hub

News

Auro Laboratories to discuss results

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 12 Novem...

Read more

07 Nov 2025 15:53

News

Auro Laboratories AGM scheduled

Auro Laboratories announced that the 36th Annual General Meeting(AGM) of the company will ...

Read more

26 Aug 2025 14:44

News

Auro Laboratories to hold board meeting

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 14 Augus...

Read more

08 Aug 2025 17:16

News

Auro Laboratories revises board meeting date

Auro Laboratories has revised the meeting of the Board of Directors which was scheduled to...

Read more

22 May 2025 11:12

News

Auro Laboratories announces board meeting date

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 23 May 2...

Read more

17 May 2025 11:47

News

Auro Laboratories to hold board meeting

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 14 Febru...

Read more

08 Feb 2025 15:07

Jagsonpal Pharmaceuticals Ltd News Hub

News

Jagsonpal Pharmaceuticals allots 56,571 equity shares under ESOP

Jagsonpal Pharmaceuticals has allotted 56,571 equity shares under ESOP on 18 November 2025...

Read more

18 Nov 2025 11:44

News

Jagsonpal Pharmaceuticals to declare Quarterly Results

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

28 Oct 2025 11:12

News

Jagsonpal Pharma appoints Nirav Vora as CFO

The appointment was made based on the recommendations of the company's nomination and remu...

Read more

08 Oct 2025 09:27

News

Jagsonpal Pharmaceuticals allots 93,445 equity shares under ESOP

Jagsonpal Pharmaceuticals has allotted 93,445 equity shares under ESOP on 07 October 2025....

Read more

07 Oct 2025 20:13

News

Jagsonpal Pharmaceuticals allots 66,000 equity shares under ESOP

Jagsonpal Pharmaceuticals has allotted 66,000 equity shares of Rs. 2/- each under JPL ESOP...

Read more

08 Aug 2025 18:25

News

Jagsonpal Pharmaceuticals AGM scheduled

Jagsonpal Pharmaceuticals announced that the 45th Annual General Meeting(AGM) of the compa...

Read more

28 Jul 2025 11:09

SWOT Analysis Of Auro Laboratories Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Jagsonpal Pharmaceuticals Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Auro Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Jagsonpal Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Auro Laboratories Ltd and Jagsonpal Pharmaceuticals Ltd

Which company has a larger market capitalization, Auro Laboratories Ltd or Jagsonpal Pharmaceuticals Ltd?

Market cap of Auro Laboratories Ltd is 155 Cr while Market cap of Jagsonpal Pharmaceuticals Ltd is 1,343 Cr

What are the key factors driving the stock performance of Auro Laboratories Ltd and Jagsonpal Pharmaceuticals Ltd?

The stock performance of Auro Laboratories Ltd and Jagsonpal Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Auro Laboratories Ltd and Jagsonpal Pharmaceuticals Ltd?

As of December 18, 2025, the Auro Laboratories Ltd stock price is INR ₹249.8. On the other hand, Jagsonpal Pharmaceuticals Ltd stock price is INR ₹201.15.

How do dividend payouts of Auro Laboratories Ltd and Jagsonpal Pharmaceuticals Ltd compare?

To compare the dividend payouts of Auro Laboratories Ltd and Jagsonpal Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions